The nuclear translocation of ERK1/2 as an anticancer target. (Q38893704)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25819065%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

The nuclear translocation of ERK1/2 as an anticancer target (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25819065%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25819065%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Alexander Plotnikov

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25819065%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Galia Maik-Rachline

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25819065%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Eldar Zehorai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25819065%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Einat Kapri-Pardes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25819065%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Denise A Berti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25819065%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Tamar Hanoch

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25819065%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Michal J Besser

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25819065%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Rony Seger

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25819065%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

30 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25819065%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

published in

Nature Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25819065%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25819065%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

6685

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25819065%20AND%20SRC:MED&resulttype=core&format=json

The ERK Cascade: Distinct Functions within Various Subcellular Organelles

4 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

The MAP Kinase Signaling Cascades: A System of Hundreds of Components Regulates a Diverse Array of Physiological Functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Signal control through Raf: in sickness and in health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Improved survival with MEK inhibition in BRAF-mutated melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Small‐Molecule Inhibitors of the ERK Signaling Pathway: Towards Novel Anticancer Therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Progression of RAS-mutant leukemia during RAF inhibitor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Resistance to BRAF inhibition in melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

The ERK signaling cascade--views from different subcellular compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Nuclear localization and regulation of erk- and rsk-encoded protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Protein-protein interactions in the regulation of the extracellular signal-regulated kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Identification and characterization of a general nuclear translocation signal in signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

RETRACTED: Nuclear Extracellular Signal-Regulated Kinase 1 and 2 Translocation Is Mediated by Casein Kinase 2 and Accelerated by Autophosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

The subcellular localization of MEK and ERK--a novel nuclear translocation signal (NTS) paves a way to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

ERK dimers and scaffold proteins: unexpected partners for a forgotten (cytoplasmic) task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

RETRACTED: Beta-like importins mediate the nuclear translocation of mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Myristoyl-based transport of peptides into living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Structure based design of novel 6,5 heterobicyclic mitogen-activated protein kinase kinase (MEK) inhibitors leading to the discovery of imidazo[1,5-a] pyrazine G-479

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Mitogen-activated protein kinase inhibition induces translocation of Bmf to promote apoptosis in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

BuCy RAFs drive cells into MEK addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Nuclear entry of activated MAPK is restricted in primary ovarian and mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Resistance to selective BRAF inhibition can be mediated by modest upstream pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

Prolactin-stimulated activation of ERK1/2 mitogen-activated protein kinases is controlled by PI3-kinase/Rac/PAK signaling pathway in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

MEK1 is required for PTEN membrane recruitment, AKT regulation, and the maintenance of peripheral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7685

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/25819065

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Stimulated nuclear import by β-like importins

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25819065

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Use of transduction proteins to target trabecular meshwork cells: outflow modulation by profilin I

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25819065

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NCOMMS7685

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25819065%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 March 2020

ADS bibcode

2015NatCo...6.6685P

0 references

1013351045

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25819065%20AND%20SRC:MED&resulttype=core&format=json